GO:0004342 glucosamine-6-phosphate deaminase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

• GO:0004342 describes the enzymatic activity that converts D-glucosamine 6-phosphate and water into beta-D-fructose 6-phosphate and ammonium.
• The enzyme is widely conserved, from bacteria and archaea to mammals, and is essential for amino sugar metabolism and cell wall biosynthesis in microbes.
• In humans, glucosamine-6-phosphate deaminase is expressed in transporting epithelia and red blood cells, where it may contribute to hexosamine flux.
• The enzyme has been studied as a potential drug target in parasites such as Plasmodium falciparum and Giardia lamblia.
• Its catalytic mechanism involves ring opening, isomerization, and deamination steps, and the enzyme can exist in different oligomeric states.
• CRISPR-based knockout, knock-in, and overexpression models enable precise interrogation of this enzyme's role in metabolism and disease.

Description

Glucosamine-6-phosphate deaminase (EC 3.5.99.6) is a metabolic enzyme that catalyzes the reversible conversion of D-glucosamine 6-phosphate (GlcN6P) to beta-D-fructose 6-phosphate (Fru6P) with the release of ammonium. This reaction is a key step in the hexosamine biosynthetic pathway and in the catabolism of amino sugars, linking carbohydrate and amino sugar metabolism. The enzyme is found across all domains of life, from hyperthermophilic archaea to mammals, underscoring its fundamental importance. In bacteria, it is involved in cell wall peptidoglycan synthesis and in the utilization of GlcN6P as a carbon and nitrogen source. In humans, the enzyme is expressed in transporting epithelia and erythrocytes, where it may regulate hexosamine flux and contribute to metabolic homeostasis. Because of its central role in amino sugar metabolism, glucosamine-6-phosphate deaminase has attracted interest as a potential target for antimicrobial and antiparasitic therapies. This article provides a comprehensive overview of GO:0004342, covering its definition, mechanism, key genes, disease relevance, and modern research methods including CRISPR-based models.

glucosamine-6-phosphate deaminase activity At A Glance

GO ID GO:0004342
GO term glucosamine-6-phosphate deaminase activity
Ontology molecular_function
Synonym GlcN6P deaminase activity; glucosamine-6-phosphate isomerase activity; phosphoglucosamine isomerase activity
Major function Catalyzes the conversion of D-glucosamine 6-phosphate to beta-D-fructose 6-phosphate and ammonium
EC number 3.5.99.6
Reaction D-glucosamine 6-phosphate + H2O = beta-D-fructose 6-phosphate + NH4
Organisms Bacteria, archaea, protozoa, mammals
Subcellular location Cytoplasm (in most organisms)

What Is GO:0004342?

GO:0004342, glucosamine-6-phosphate deaminase activity, is defined as the catalysis of the reaction: D-glucosamine 6-phosphate + H2O = beta-D-fructose 6-phosphate + NH4. In other words, it is an enzyme that removes an amino group from glucosamine 6-phosphate, converting it to fructose 6-phosphate and releasing ammonium. This activity is also known as glucosamine-6-phosphate isomerase or GlcN6P deaminase.

Why Is glucosamine-6-phosphate deaminase activity Important in Cell Biology?

Glucosamine-6-phosphate deaminase activity is critical for amino sugar metabolism, which feeds into glycolysis, peptidoglycan biosynthesis, and protein glycosylation. In microorganisms, it is essential for cell wall integrity and for utilizing amino sugars as nutrients. In humans, it may influence hexosamine flux and insulin sensitivity, and its expression in transporting epithelia suggests a role in metabolic regulation. The enzyme is also a potential drug target in parasites like Plasmodium falciparum and Giardia lamblia, where it is required for survival. Thus, understanding GO:0004342 has broad implications for microbiology, parasitology, and human metabolic diseases.
• Essential for amino sugar metabolism and hexosamine biosynthesis.
• Required for bacterial cell wall peptidoglycan synthesis.
• Potential drug target in parasitic infections such as malaria and giardiasis.
• Expressed in human transporting epithelia and erythrocytes, suggesting roles in metabolic homeostasis.
• Involved in hyperthermophilic archaeal metabolism, indicating ancient evolutionary origin.
• Can exist in multiple oligomeric states, affecting catalytic regulation.
• Studied for biotechnological production of glucosamine from D-fructose.
• Provides a model for understanding enzyme mechanism and allostery.
• Links carbohydrate and nitrogen metabolism.
• Relevant to metabolic engineering and synthetic biology.

Mechanism, Genes and Research Methods

Substrate Binding and Ring Opening
In simple terms: The enzyme grabs glucosamine 6-phosphate and opens its sugar ring.
The catalytic cycle begins with the binding of D-glucosamine 6-phosphate to the active site of the enzyme. The substrate's pyranose ring is opened to form a linear intermediate, which is essential for subsequent isomerization and deamination steps. Structural studies of the enzyme from dog kidney cortex have provided insights into substrate binding and catalytic residues.
Isomerization and Deamination
In simple terms: The enzyme rearranges the sugar and removes an amino group, releasing ammonium.
Following ring opening, the enzyme catalyzes an isomerization step that converts the amino sugar into a keto sugar intermediate. This is followed by deamination, which releases ammonium and yields beta-D-fructose 6-phosphate. The reaction is reversible, allowing the enzyme to also catalyze the reverse reaction in some organisms.
Oligomeric States and Regulation
In simple terms: The enzyme can assemble into different shapes, which may affect its activity.
Glucosamine-6-phosphate deaminase from various organisms can exist as dimers, hexamers, or other oligomeric forms. For example, the enzyme from Giardia lamblia shows heterogeneity in quaternary structure, and a dimer-hexamer equilibrium has been observed in the glucosamine-6-phosphate deaminase family. These oligomeric variations may regulate enzyme activity and stability.
Catalytic Mechanism and Cofactors
In simple terms: The enzyme uses specific amino acids to perform the reaction without needing extra cofactors.
The catalytic mechanism of glucosamine-6-phosphate deaminase does not require metal ions or cofactors; instead, it relies on conserved amino acid residues to facilitate ring opening, isomerization, and deamination. Site-directed mutagenesis and kinetic studies have identified key residues involved in catalysis.
Evolutionary and Structural Diversity
In simple terms: The enzyme is found in many organisms and has adapted to different environments.
Glucosamine-6-phosphate deaminase is present in bacteria, archaea, and eukaryotes. A hyperthermophilic archaeal enzyme has been characterized, showing thermostability and unique structural features. Mammalian enzymes, such as the human one, localize to transporting epithelia and lack oscillin activity, distinguishing them from other related proteins.

Key Genes Involved in GO:0004342 glucosamine-6-phosphate deaminase activity

The following genes encode glucosamine-6-phosphate deaminase or related proteins across different organisms.
GeneMajor RoleResearch Relevance
nagB (E. coli) Encodes glucosamine-6-phosphate deaminase for amino sugar catabolism Model for enzyme mechanism and regulation
glmS (Bacillus subtilis) Glucosamine-6-phosphate synthase, related to amino sugar metabolism Indirectly linked to deaminase pathway
GNPDA1 (human) Encodes glucosamine-6-phosphate deaminase 1 Expressed in transporting epithelia; potential metabolic role
GNPDA2 (human) Encodes glucosamine-6-phosphate deaminase 2 Isoform with distinct tissue distribution
PfGNPDA (P. falciparum) Glucosamine-6-phosphate deaminase in malaria parasite Potential drug target
GlGNPDA (G. lamblia) Glucosamine-6-phosphate deaminase in Giardia Shows oligomeric heterogeneity
hGNPDA (human erythrocytes) Glucosamine-6-phosphate deaminase in red blood cells Studied for hexosamine metabolism
Dog kidney GNPDA Purified and characterized enzyme Model for kinetics and structure
Archaeal GNPDA Hyperthermophilic enzyme Model for thermostability
nagA (E. coli) N-acetylglucosamine-6-phosphate deacetylase Upstream of deaminase in amino sugar pathway
nagE (E. coli) PTS transporter for GlcNAc Feeds into deaminase pathway
GFAT (human) Glutamine:fructose-6-phosphate amidotransferase Produces GlcN6P, substrate for deaminase
OGT (human) O-GlcNAc transferase Uses UDP-GlcNAc from hexosamine pathway
OGA (human) O-GlcNAcase Removes O-GlcNAc, linked to hexosamine flux
GNPDA2 (mouse) Mouse ortholog of human GNPDA2 Model for metabolic studies
GNPDA1 (zebrafish) Zebrafish ortholog Developmental studies
GNPDA (Drosophila) Fruit fly ortholog Genetic studies
GNPDA (C. elegans) Nematode ortholog Aging and metabolism research

How Is glucosamine-6-phosphate deaminase activity Regulated?

Glucosamine-6-phosphate deaminase activity is regulated at multiple levels. In bacteria, the nagB gene is subject to transcriptional regulation by the NagC repressor and is induced by GlcNAc. In mammals, GNPDA1 and GNPDA2 expression may be influenced by metabolic status, although specific regulators are not fully defined. The enzyme's activity can also be modulated by its oligomeric state, as dimer-hexamer transitions affect catalysis. Additionally, allosteric regulation by metabolites such as N-acetylglucosamine-6-phosphate has been proposed in some organisms.

glucosamine-6-phosphate deaminase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
GNPDA1Metabolic disorders, insulin resistanceKnockout mouse, cell lines
GNPDA2Obesity, type 2 diabetesOverexpression in adipocytes
PfGNPDAMalariaParasite knockout, enzyme inhibitors
GlGNPDAGiardiasisGiardia knockout, drug screening
nagBBacterial infectionsBacterial knockout, antibiotic testing
Parasitic Infections
Glucosamine-6-phosphate deaminase is essential for the survival of parasites such as Plasmodium falciparum and Giardia lamblia. In P. falciparum, the enzyme is involved in amino sugar metabolism, and its inhibition could block parasite growth. Similarly, Giardia lamblia relies on this enzyme for hexosamine synthesis, making it a potential drug target.
Metabolic Disorders
In humans, glucosamine-6-phosphate deaminase may contribute to hexosamine flux, which is linked to insulin resistance and diabetes. The enzyme is expressed in transporting epithelia and erythrocytes, suggesting a role in glucose homeostasis. However, direct evidence for its involvement in metabolic diseases is still emerging.
Cancer
Altered hexosamine metabolism is a hallmark of cancer, and enzymes like glucosamine-6-phosphate deaminase may support tumor growth by providing precursors for glycosylation. While direct studies are limited, the enzyme's role in amino sugar metabolism warrants further investigation in cancer models.

From glucosamine-6-phosphate deaminase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Enzyme catalytic mechanismPoint mutations in active site residues
Role in amino sugar metabolismKnockout cell lines (e.g., HEK293)
Effect on hexosamine fluxOverexpression in mammalian cells
Parasite drug target validationKnockout in P. falciparum
Oligomeric regulationTagged knock-in for structural studies
Metabolic disease associationKnockout mouse models

How to Study the glucosamine-6-phosphate deaminase activity Process

MethodWhat It MeasuresTypical Application
Enzymatic assayCatalytic activityKinetic studies
X-ray crystallography3D structureActive site analysis
Cryo-EMOligomeric statesStructural heterogeneity
13C tracingMetabolic fluxPathway analysis
CRISPR knockoutGene functionPhenotypic screening
RNA-seqGene expressionTranscriptional regulation
ProteomicsProtein abundanceExpression profiling
Enzymatic Assays
Enzyme activity can be measured spectrophotometrically by monitoring the formation of fructose 6-phosphate or ammonium. Coupled assays with phosphoglucose isomerase and glucose-6-phosphate dehydrogenase are commonly used.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the structures of glucosamine-6-phosphate deaminase from various organisms, revealing active site architecture and oligomeric states.
Metabolic Flux Analysis
Isotope tracing with 13C-labeled glucosamine can quantify flux through the deaminase reaction in cells and tissues.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to glucosamine-6-phosphate deaminase inhibitors or regulate hexosamine metabolism.

How CRISPR Can Be Used to Study GO:0004342 glucosamine-6-phosphate deaminase activity

Knockout

CRISPR-Cas9 knockout of GNPDA1 or GNPDA2 in human cell lines can abolish enzyme activity, allowing researchers to study its role in hexosamine metabolism and cell growth.

Point Mutation

Introducing point mutations in catalytic residues (e.g., in nagB) via CRISPR base editing can dissect the mechanism of catalysis and identify essential amino acids.

Knock-in

Knock-in of tagged versions of GNPDA (e.g., FLAG or GFP) enables localization, interaction, and structural studies in native contexts.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression can increase glucosamine-6-phosphate deaminase levels, useful for studying metabolic flux and disease models.

How EDITGENE Supports glucosamine-6-phosphate deaminase activity Research

Researchers studying glucosamine-6-phosphate deaminase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for glucosamine-6-phosphate deaminase activity research.

Related Products

Product name Cat.No. Species Gene ID
GNPDA1 Knockout HEK293 Cell Line EDJ-KQ2060 Human 10007 Details Get a Quote
GNPDA2 Knockout HEK293 Cell Line EDJ-KQ9303 Human 132789 Details Get a Quote
GNPDA1 Knockout A-549 Cell Line EDJ-KQ22126 Human 10007 Details Get a Quote
GNPDA1 Knockout HCT 116 Cell Line EDJ-KQ22127 Human 10007 Details Get a Quote
GNPDA1 Knockout HeLa Cell Line EDJ-KQ22128 Human 10007 Details Get a Quote
GNPDA2 Knockout HCT 116 Cell Line EDJ-KQ35917 Human 132789 Details Get a Quote
GNPDA2 Knockout HeLa Cell Line EDJ-KQ35918 Human 132789 Details Get a Quote
GNPDA2 Knockout A-549 Cell Line EDJ-KQ34674 Human 132789 Details Get a Quote

Frequently Asked Questions About glucosamine-6-phosphate deaminase activity

It is an enzymatic activity (GO:0004342) that converts D-glucosamine 6-phosphate to beta-D-fructose 6-phosphate and ammonium.
Key genes include GNPDA1 and GNPDA2 in humans, nagB in bacteria, and orthologs in parasites and archaea.
D-glucosamine 6-phosphate + H2O = beta-D-fructose 6-phosphate + NH4.
It is essential for amino sugar metabolism, cell wall biosynthesis in microbes, and potentially for human metabolic regulation.
Yes, it is being explored as a target in parasites like Plasmodium falciparum and Giardia lamblia.
Regulation occurs at transcriptional, post-translational, and oligomeric levels, with nagB being controlled by NagC in bacteria.
Parasitic infections, metabolic disorders, and potentially cancer through altered hexosamine metabolism.
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect its function.
Enzymatic assays, structural biology, metabolic flux analysis, and CRISPR screening are common methods.
It is expressed in transporting epithelia and erythrocytes.

Conclusion

Glucosamine-6-phosphate deaminase activity (GO:0004342) is a fundamental enzymatic function in amino sugar metabolism with broad relevance across microbiology, parasitology, and human health. Its conserved mechanism, diverse oligomeric states, and potential as a drug target make it an attractive subject for research. Advances in CRISPR-based models and metabolic profiling will continue to illuminate its roles in disease and biotechnology.

References

  1. 1. Zhang ZH et al.. 2025. Semi-rational engineering of glucosamine-6-phosphate deaminase for catalytic synthesis of glucosamine from D-fructose.. Enzyme Microb Technol 183:110552 PMID: 39615319
  2. 2. Srinivasachari S et al.. 2023. A dimer between monomers and hexamers-Oligomeric variations in glucosamine-6-phosphate deaminase family.. PLoS One 18(1):e0271654 PMID: 36598911
  3. 3. Wolosker H et al.. 1998. Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity.. FASEB J 12(1):91-9 PMID: 9438414
  4. 4. Weidanz JA et al.. 1995. Glucosamine 6-phosphate deaminase in Plasmodium falciparum.. Br J Haematol 91(3):578-86 PMID: 8555058
  5. 5. Tanaka T et al.. 2005. Characterization of a novel glucosamine-6-phosphate deaminase from a hyperthermophilic archaeon.. J Bacteriol 187(20):7038-44 PMID: 16199574
  6. 6. Kwiatkowska-Semrau K et al.. 2015. Heterogeneity of quaternary structure of glucosamine-6-phosphate deaminase from Giardia lamblia.. Parasitol Res 114(1):175-84 PMID: 25326378
  7. 7. Weidanz JA et al.. 1995. Glucosamine 6-phosphate deaminase in normal human erythrocytes.. Br J Haematol 91(1):72-9 PMID: 7577655
  8. 8. Lara-Lemus R et al.. 1992. Purification and characterization of glucosamine-6-phosphate deaminase from dog kidney cortex.. Arch Biochem Biophys 297(2):213-20 PMID: 1497340
Contact Us
*
*
*
How did you hear about us: